Detailed information for compound 444148

Basic information

Technical information
  • TDR Targets ID: 444148
  • Name: 1-[[5-(aminomethyl)-1-(4-hydroxybutyl)benzimi dazol-2-yl]methyl]-3-(2,2,2-trifluoroethyl)qu inazoline-2,4-dione
  • MW: 475.464 | Formula: C23H24F3N5O3
  • H donors: 2 H acceptors: 4 LogP: 1.79 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: OCCCCn1c(nc2c1ccc(c2)CN)Cn1c2ccccc2c(=O)n(c1=O)CC(F)(F)F
  • InChi: 1S/C23H24F3N5O3/c24-23(25,26)14-31-21(33)16-5-1-2-6-18(16)30(22(31)34)13-20-28-17-11-15(12-27)7-8-19(17)29(20)9-3-4-10-32/h1-2,5-8,11,32H,3-4,9-10,12-14,27H2
  • InChiKey: LTKNCUZYJXBATJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-[[5-(aminomethyl)-1-(4-hydroxybutyl)-2-benzimidazolyl]methyl]-3-(2,2,2-trifluoroethyl)quinazoline-2,4-dione
  • 1-[[5-(aminomethyl)-1-(4-hydroxybutyl)benzimidazol-2-yl]methyl]-3-(2,2,2-trifluoroethyl)quinazoline-2,4-quinone

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium tuberculosis Probable oxidoreductase 0.0049 0 0.5
Mycobacterium ulcerans oxidoreductase GMC-type 0.0049 0 0.5
Toxoplasma gondii FAD binding domain-containing protein 0.0049 0 0.5
Echinococcus multilocularis transcription factor Dp 1 0.0225 0.5186 0.5186
Wolbachia endosymbiont of Brugia malayi 2-polyprenyl-6-methoxyphenol 4-hydroxylase 0.0049 0 0.5
Leishmania major tyrosyl-DNA phosphodiesterase 1 0.0389 1 1
Plasmodium falciparum FAD-dependent monooxygenase, putative 0.0049 0 0.5
Echinococcus granulosus transcription factor Dp 1 0.0225 0.5186 0.5186
Echinococcus granulosus retinoic acid receptor rxr beta a 0.0315 0.7828 0.7828
Plasmodium vivax hypothetical protein, conserved 0.0049 0 0.5
Trypanosoma brucei tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0389 1 1
Entamoeba histolytica tyrosyl-DNA phosphodiesterase, putative 0.0389 1 0.5
Mycobacterium tuberculosis Probable oxidoreductase 0.0049 0 0.5
Toxoplasma gondii FAD binding domain-containing protein 0.0049 0 0.5
Trypanosoma cruzi tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0389 1 1
Mycobacterium tuberculosis Possible oxidoreductase 0.0049 0 0.5
Mycobacterium ulcerans oxidoreductase 0.0049 0 0.5
Echinococcus multilocularis tyrosyl DNA phosphodiesterase 1 0.0389 1 1
Mycobacterium tuberculosis Possible oxidoreductase 0.0049 0 0.5
Mycobacterium ulcerans oxidoreductase 0.0049 0 0.5
Mycobacterium ulcerans hypothetical protein 0.0049 0 0.5
Chlamydia trachomatis monooxygenase 0.0049 0 0.5
Mycobacterium tuberculosis Possible oxidoreductase 0.0049 0 0.5
Trypanosoma cruzi tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0389 1 1
Mycobacterium ulcerans membrane-associated oxidoreductase 0.0049 0 0.5
Mycobacterium ulcerans hypothetical protein 0.0049 0 0.5
Schistosoma mansoni retinoic acid receptor RXR 0.0315 0.7828 0.7828
Mycobacterium ulcerans hypothetical protein 0.0049 0 0.5
Echinococcus granulosus tyrosyl DNA phosphodiesterase 1 0.0389 1 1
Echinococcus multilocularis retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha 0.0303 0.7479 0.7479
Schistosoma mansoni tyrosyl-DNA phosphodiesterase 0.0389 1 1
Mycobacterium ulcerans FAD-dependent oxidoreductase 0.0049 0 0.5
Mycobacterium ulcerans FAD-linked oxidoreductase 0.0049 0 0.5
Mycobacterium leprae possibleputative FAD-linked oxidoreductase 0.0049 0 0.5
Plasmodium vivax FAD-dependent monooxygenase, putative 0.0049 0 0.5
Loa Loa (eye worm) tyrosyl-DNA phosphodiesterase 0.0389 1 1

Activities

Activity type Activity value Assay description Source Reference
CC50 (ADMET) = 52.68 uM Cytotoxicity against human Hep2 cells ChEMBL. 17616396
EC50 (functional) = 0.008 uM Antiviral activity against RSV Long in Hep2 cells ChEMBL. 17616396
EC50 (functional) > 0.5 uM Antiviral activity against RSV Long with F1 protein K349R mutation in Hep2 cells ChEMBL. 17616396

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.